You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firms have already completed proof-of-concept studies for their semiconductor biosensor chips and Roswell plans to have the initial chips by 2021.
The Genetron Health S5 NGS system is based on the Thermo Fisher Scientific Ion GeneStudio S5 and will be accompanied by Genetron-developed assays.
Researchers at the Jackson Laboratory have tested an early version of the GenapSys sequencer and found it to have a very low mismatch error rate.
The Redwood, California-based company plans to use the funding to drive the commercial launch of its semiconductor chip-based sequencing-by-synthesis instrument.
The startup is developing a semiconductor chip for single-molecule sequencing and plans to make the technology available to early-access customers by the end of this year.
At the JP Morgan Healthcare conference, Illumina unveiled the semiconductor-based sequencing system it has been developing as part of its Firefly project.
Under the contract, DNAe will develop tests for antimicrobial resistant infections and influenza that it submits to the FDA for clearance.
Earlier this month at AGBT, company researchers presented the new developments, which Thermo Fisher plans to roll out later this year.
Illumina's CEO described the one-channel chemistry behind Firefly, saying that its simplicity would allow it to be deployed into new markets, including hospitals.
The company also announced the Infinium XT genotyping array for analyzing large sample numbers, and provided preliminary earnings for Q4 and full-year 2015.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.